Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYVITS: Triple Therapy for Septic Shock
NCT03380507Phase 3Terminated
- Sponsor
- Hamad Medical Corporation
- Start
- Mar 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydrocortisone, ascorbic acid, thiamine in septic shock, sponsored by Hamad Medical Corporation. Started Mar 2018; status: terminated.
02
Drugs
hydrocortisoneascorbic acidthiamine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03380507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03380507.